| S5472 |
Nafronyl oxalate salt |
Nafronyl oxalate salt is the oxalate salt form of nafronyl, which is a selective antagonist of 5-HT2 receptors and a vasodilator used in the management of peripheral and cerebral vascular disorders. |
Selective |
|
| S4283 |
Cyclobenzaprine HCl |
Cyclobenzaprine HCl(Cyclobenzaprine hydrochloride) is a muscle relaxant by blocking pain sensations, used for the treatment of muscle spasms; A 5-HT2 receptor antagonist.
|
Selective |
|
| S5770 |
Pizotifen |
Pizotifen (Pizotyline, BC-105) is a potent antagonist of 5-Hydroxytryptamine (5-HT, Serotonin) 5-HT2 receptor with a high affinity for 5-HT1C binding site. |
Selective |
|
| S2698 |
RS-127445 |
RS-127445 (MT500) is a selective 5-HT2B receptor antagonist with pKi of 9.5 and pIC50 of 10.4, exhibits >1000-fold selectivity against other 5-HT receptors. |
Selective |
5-HT2B, pKi: 9.5; 5-HT2B, pIC50: 10.4 |
| S3706 |
Sarpogrelate hydrochloride |
Sarpogrelate (MCI-9042) is a selective 5-HT2A antagonist with pKi values of 8.52, 7.43 and 6.57 for 5-HT2A, 5-HT2C and 5-HT2B receptors respectively. |
Selective |
5-HT2A, Kd: 0.2 nM; 5-HT2B, Ki: 2.1 nM; 5-HT2C, Kd: 1.1 nM; 5-HT2B, Kd: 2.1 nM |
| S0313 |
Volinanserin |
Volinanserin (Volinanserin Hydrochloride Salt, MDL100907, M 100907, MDL-100,907) is a highly selective and potent 5-HT2 receptor antagonist with Ki of 0.36 nM. Volinanserin shows antipsychotic activity. |
Selective |
5-HT2 receptor, Ki: 0.36 nM |
| S4635 |
Cyproheptadine hydrochloride sesquihydrate |
Cyproheptadine hydrochloride (Periactin, Peritol) is non-selective 5HT2 antagonist with IC50 of 0.6 nM. Also a SETD7/9 inhibitor. |
Selective |
5-HT2, IC50: 0.6 nM |
| S8183 |
Pimavanserin tartrate |
Pimavanserin tartrate(ACP-103) is a potent and selective serotonin 5-HT2A inverse agonist with pIC50 of 8.73, used to treat psychosis associated with Parkinson’s disease. |
Selective |
5-HT2A, pIC50: 8.7 |
| S2232 |
Ketanserin |
Ketanserin (R41468, Ketanserinum) is a specific 5-HT2A serotonin receptor antagonist with Ki of 2.5 nM for rat and human 5-HT2A, used as an antihypertensive drug. |
Selective |
5-HT2A, Ki: 2.5 nM; 5-HT2C (Rat), Ki: 50 nM; 5-HT2C (Human), Ki: 100 nM |
| S8010 |
PRX-08066 Maleic acid |
PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2. |
Selective |
5-HT2B, IC50: 3.4 nM |
| S2112 |
Blonanserin |
Blonanserin (AD 5423) is a relatively selective serotonin (5-HT)2A and dopamine D2 antagonist, used the treatment of schizophrenia. |
Selective |
5-HT2, Ki: 3.98 nM |
| S4086 |
Loxapine Succinate |
Loxapine Succinate(NSC 759578) is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent. |
Selective |
5-HT2 (human), Ki: 6.2 nM; 5-HT2 (bovine), Ki: 6.8 nM; 5-HT2 (bovine), Ki: 6.6 nM |
| S0476 |
SCH-23390 hydrochloride |
SCH-23390 hydrochloride (R-(+)-SCH-23390, SCH-23390) is a highly potent and selective dopamine D1-like receptor antagonist with Ki of 0.2 nM and 0.3 nM for the D1 and D5 dopamine receptor subtypes, respectively. SCH-23390 hydrochloride is a potent and high efficacy agonist at h5-HT2C receptors with Ki of 9.3 nM. SCH-23390 hydrochloride directly inhibits G protein-coupled inwardly rectifying potassium (GIRK) channels with IC50 of 268 nM. |
Selective |
h5-HT2C receptor, Ki: 9.3 nM |
| S0893 |
SB-200646A |
SB-200646A is the first selective 5-HT2B/2C over 5-HT2A receptor antagonist with pKi values of 7.5, 6.9 and 5.2 for 5-HT2B, 5-HT2C and 5-HT2A, respectively. |
Selective |
5-HT2B, pKi: 7.5; 5-HT2C, pKi: 6.9; 5-HT2A, pKi: 5.2 |
| S2649 |
SB 200646 |
SB 200646 (SB 200646A) is a potent, selective and oral-active antagonist of 5-HT2B/2C over 5-HT2A receptor with 50 fold selectivity. The pKi for rat 5-HT2C receptor, rat 5-HT2B receptor and rat 5-HT2A receptor are 6.9, 7.5 and 5.2, respectively. SB 200646 has electrophysiological and anxiolytic properties in vivo. |
Selective |
5-HT2C (Rat), pKi: 6.9; 5-HT2B (rat), pKi: 7.5; 5-HT2A (rat), pKi: 5.2 |
| S3183 |
Amitriptyline HCl |
Amitriptyline HCl is an inhibitor of both serotonin transporter (SERT) and norepinephrine transporter (NET) with Ki of 3.45 nM and 13.3 nM, respectively. Amitriptyline HCl also inhibits histamine receptor H1, histamine receptor H4, 5-HT2 and sigma 1 receptor with Ki of 0.5 nM, 7.31 nM, 235 nM and 287 nM, respectively. Amitriptyline is a tricyclic antidepressant (TCA). |
Selective |
5-HT2, Ki: 235 nM |
| S0939 |
γ-Mangostin |
γ-Mangostin (Gamma-Mangostin) is a novel competitive 5-hydroxytryptamine 2A (5-HT2A) receptors antagonist, which can reduce the perfusion pressure response of rat coronary artery to 5-HT2A with an IC50 of 0.32 µM and inhibit [3H] spiperone binding to cultured rat aortic myocytes with an IC50 of 3.5 nM. Gamma-Mangostin is also an inhibitor of Transthyretin (TTR) fibrillization. |
Selective |
5-HT2A, IC50: 0.32 μM |
| S1243 |
Agomelatine (S20098) |
Agomelatine (Valdoxan, Melitor, Thymanax,S20098) is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. |
Selective |
|
| S2459 |
Clozapine |
Clozapine (HF 1854, LX 100-129) is an atypical antipsychotic drug by acting as a 5-HT antagonist, used in the treatment of schizophrenia. |
Selective |
|
| S2493 |
Olanzapine |
Olanzapine (LY170053,Zyprexa, Zalasta, Zolafren, Olzapin, Oferta, Zypadhera) is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist. |
Selective |
|
| S1283 |
Asenapine maleate |
Asenapine maleate (Org 5222) is a high-affinity antagonist of serotonin, norepinephrine, dopamine and histamine receptors, used for the treatment of schizophrenia and acute mania associated with bipolar disorder. |
Pan |
5-HT2A, pKi: 10.15; 5-HT2B, pKi: 9.75; 5-HT2C, pKi: 10.46 |
| S3913 |
Pimethixene maleate |
Pimethixene (Pimetixene) maleate, an antihistamine, anntimigraine agent and antiserotonergic compound, is a highly potent antagonist of a broad range of monoamine receptors, including a variety of serotonin receptors. Pimethixene maleate inhibits 5-HT2A, 5-HT2B, 5-HT2C, 5-HT1A, 5-HT1B, 5-HT6, 5-HT7, Adrenergic α-1A, Dopamine D1 Receptor, Dopamine D2 Receptor, Dopamine D4.4 Receptor, Histamine H1 Receptor, Muscarinic M1 and Muscarinic M2 with pKi of 10.22, 10.44, 8.42, 7.63, < 5, 7. |
Pan |
5-HT2A, pKi: 10.22; 5-HT2B, pKi: 10.44; 5-HT2C, pKi: 8.42 |
| S1615 |
Risperidone |
Risperidone (R-64766) is a mutil-targeted antagonist for dopamine, serotonin, adrenergic and histamine receptors, used to treat schizophrenia and bipolar disorder. |
Pan |
5-HT2A, Ki: 0.17 nM; 5-HT2B, Ki: 61.9 nM; 5-HT2C, Ki: 12 nM |
| S5714 |
lurasidone |
Lurasidone (SM-13496) is a second-generation antipsychotic agent that exhibits full antagonism at dopamine D2 and serotonin 5-HT2A receptors with binding affinities Ki = 1 nM and Ki = 0.5 nM, respectively. It also has high affinity for serotonin 5-HT7 receptors (Ki = 0.5 nM), partial agonist activity at 5-HT1A receptors (Ki = 6.4 nM) and lacks affinity for histamine H1 and muscarinic M1 receptors. |
Pan |
5-HT2A, Ki: 0.5 nM |
| S5185 |
Perospirone |
Perospirone (SM-9018 free base) is an orally active antagonist of 5-hydroxytryptamine2 (5-HT2) receptor, dopamine2 (D2) receptor and 5-HT1A receptor with Ki of 0.6 nM, 1.4 nM and 2.9 nM, respectively. |
Pan |
5-HT2 receptor, Ki: 0.6 nM |
| S4889 |
Perospirone hydrochloride |
Perospirone (SM-9018) is an atypical or second-generation antipsychotic of the azapirone family that antagonizes serotonin 5HT2A receptors and dopamine D2 receptors. It also displays affinity towards 5HT1A receptors as a partial agonist. |
Pan |
5-HT2 receptor, Ki: 0.61 nM |
| S2677 |
BRL-15572 Dihydrochloride |
BRL-15572 is a 5-HT1D receptor antagonist with pKi of 7.9, also shows a considerable affinity at 5-HT1A and 5-HT2B receptors, exhibiting 60-fold selectivity over 5-HT1B receptor. |
Pan |
5-HT2A, pKi: 6.6; 5-HT2B, pKi: 7.4; 5-HT2C, pKi: 6.2 |
| S3716 |
Flibanserin |
Flibanserin (BIMT-17, BIMT-17-BS) is a nonhormonal, centrally acting molecule that acts as an agonist at postsynaptic 5-HT1A receptors and as an antagonist at 5-HT2A receptors. |
Pan |
5-HT2A, Ki: 49 nM |
| S2691 |
BMY 7378 Dihydrochloride |
BMY 7378 is a multi-targeted inhibitor of α2C-adrenoceptor and α1D-adrenoceptor with pKi of 6.54 and 8.2, respectively, and acts as a mixed agonist and antagonist for 5-HT1A receptor with pKi of 8.3. |
Pan |
5-HT2, pIC50: 5.5 |
| S5843 |
Cinitapride Hydrogen Tartrate |
Cinitapride Hydrogen Tartrate is a gastroprokinetic agent that acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors |
Pan |
|
